Company registration number 14039646 (England and Wales)
S.C.S.K MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
S.C.S.K MEDICAL LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
S.C.S.K MEDICAL LIMITED
BALANCE SHEET
AS AT
30 APRIL 2025
30 April 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
2,077
1,050
Current assets
Cash at bank and in hand
14,969
10,891
Creditors: amounts falling due within one year
4
(5,259)
(5,830)
Net current assets
9,710
5,061
Net assets
11,787
6,111
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
11,786
6,110
Total equity
11,787
6,111
S.C.S.K MEDICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 APRIL 2025
30 April 2025
- 2 -

For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 19 January 2026
S Nazli
Director
Company registration number 14039646 (England and Wales)
S.C.S.K MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
- 3 -
1
Accounting policies
1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.true

1.3
Turnover

Revenue is the provision of professional medical services.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% on cost
Computers
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

S.C.S.K MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
1
Accounting policies
(Continued)
- 4 -
1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Company information

S.C.S.K Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is 6 Alicia Drive, Rochdale, Lancashire, OL12 6JW.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
S.C.S.K MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
- 5 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 May 2024
1,400
Additions
2,770
Disposals
(1,400)
At 30 April 2025
2,770
Depreciation and impairment
At 1 May 2024
350
Depreciation charged in the year
693
Eliminated in respect of disposals
(350)
At 30 April 2025
693
Carrying amount
At 30 April 2025
2,077
At 30 April 2024
1,050
4
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
1,642
1,691
Other creditors
3,617
4,139
5,259
5,830
5
Financial commitments, guarantees and contingent liabilities

The director is not aware of any contingent liabilities.

6
Events after the reporting date

There have been no significant post balance sheet events.

2025-04-30 2024-05-01 false false false 20 January 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity S Nazli 14039646 2024-05-01 2025-04-30 14039646 2025-04-30 14039646 2024-04-30 14039646 core:OtherPropertyPlantEquipment 2025-04-30 14039646 core:OtherPropertyPlantEquipment 2024-04-30 14039646 core:WithinOneYear 2025-04-30 14039646 core:WithinOneYear 2024-04-30 14039646 core:CurrentFinancialInstruments 2025-04-30 14039646 core:CurrentFinancialInstruments 2024-04-30 14039646 core:ShareCapital 2025-04-30 14039646 core:ShareCapital 2024-04-30 14039646 core:RetainedEarningsAccumulatedLosses 2025-04-30 14039646 core:RetainedEarningsAccumulatedLosses 2024-04-30 14039646 bus:Director1 2024-05-01 2025-04-30 14039646 core:FurnitureFittings 2024-05-01 2025-04-30 14039646 core:ComputerEquipment 2024-05-01 2025-04-30 14039646 2023-05-01 2024-04-30 14039646 core:OtherPropertyPlantEquipment 2024-04-30 14039646 core:OtherPropertyPlantEquipment 2024-05-01 2025-04-30 14039646 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 14039646 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 14039646 bus:FRS102 2024-05-01 2025-04-30 14039646 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 14039646 bus:FullAccounts 2024-05-01 2025-04-30 xbrli:pure xbrli:shares iso4217:GBP